GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (OSTO:XVIVO) » Definitions » 3-Year EPS without NRI Growth Rate
中文

Xvivo Perfusion AB (OSTO:XVIVO) 3-Year EPS without NRI Growth Rate

: 0.00% (As of Dec. 2023)
View and export this data going back to 2012. Start your Free Trial

Xvivo Perfusion AB's EPS without NRI for the three months ended in Dec. 2023 was kr2.29.

During the past 12 months, Xvivo Perfusion AB's average EPS without NRI Growth Rate was 394.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 12 years, the highest 3-Year average EPS without NRI Growth Rate of Xvivo Perfusion AB was 51.00% per year. The lowest was -42.60% per year. And the median was 12.30% per year.


Competitive Comparison

For the Medical Devices subindustry, Xvivo Perfusion AB's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB 3-Year EPS without NRI Growth Rate Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's 3-Year EPS without NRI Growth Rate falls into.



Xvivo Perfusion AB 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Xvivo Perfusion AB  (OSTO:XVIVO) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Xvivo Perfusion AB 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (OSTO:XVIVO) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (OSTO:XVIVO) Headlines

No Headlines